News

Patients with obstructive sleep apnea had higher levels of inflammatory biomarkers of IL-6, TNF-α, and hsCRP levels compared to the control group.

The results of meta-analysis showed that telemedicine methods were more effective in treating chronic insomnia than in-person methods.

Soumya D. Chakravarty, MD, PhD, discusses the growing body of clinical evidence evaluating joint efficacy, safety, and patient-reported outcomes in patients with psoriatic arthritis receiving guselkumab.

Dr. Avidan speaks of the increased prevalence of insomnia and sleep-wake patterns and promising new therapies for sleep disorders including narcolepsy.

Consistent quantitative evidence of sleep disturbance in this population has been associated with staff distress, resident agitation, and prescription of psychotropic medications.

Free or total 25(OH)D serum levels were not associated with psoriasis disease severity in this small study of biologic-naïve patients.

Dr. Garcia-Molina speaks to how smart bed technology can unobtrusively collect data to predict and track the development of symptoms associated with respiratory illnesses.

Geriatric dermatology is an emerging field in the world of skin studies, with complications including cognition, polypharmacy, mobility, social support, and sleep disturbance affecting access to care.

Findings suggest mortality risk from the respiratory virus is twice greater among adults with CHF.

As influenza A(H3N2) remains the most prevalent subtype in the US, investigators estimated the available flu shot is not significantly preventing positive cases.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending March 12, 2021.

Investigators examined the effect that pulsed low-intensity ultrasonography had on symptom relief and tibiofemoral articular cartilage thickness among patients with knee osteoarthritis.

Ribotype 046 was highly prevalent during the 2011 C difficile outbreak at a hospital in Sweden.

Clinical decision support intervention resulted in a rate of change in total modifiable CV risk that was 4% lower among intervention patients compared to control.

Trauma patients and patients treated with combination ABX therapy were at an increased risk of C difficile infections.

Patients with tachyarrhythmia or hypertension as their underlying trigger of type 2 MI had a lower mortality than patients with hypotension, hypoxemia, or anemia.

Mindfulness-oriented recovery enhancement is unlike other mindfulness-based treatments and was found superior to supportive group psychotherapy for treating opioid misuse and chronic pain.

“Kawasaki disease continues to be an area of evolving understanding in clinical treatment,” said Mark Gorelik, MD, lead investigator of the guideline.

There is a significant direct correlation between post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impendence for patients with GERD.

Daniel J. Lovell, MD, MPH, explains the recent ACR guidelines updates regarding the treatment and management of juvenile idiopathic arthritis and the clinical significance of the changes.

Patients who screened positive for depression had worse dry eye symptoms and overall signs but similar inflammatory markers compared to those negative for depression.

A new study estimates that 18.2 million excess deaths occurred between January 1, 2020, and December 31, 2021, suggesting that the impact of the pandemic was greater than previously thought.

Children with strabismus had higher odds of having anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder compared to those without eye diseases.

Clinical improvement was identified in 63% of patients treated with continuous enteral vancomycin.

Primary results from these 2 phase 3 trials demonstrated efficacy and safety of the biologic through 16 weeks in patients with atopic dermatitis, but longer-term outcomes remained unknown.

Policy expert, Cindy Steinberg, of the US Pain Foundation explains the updated changes that have been proposed by the CDC to the Clinical Guideline for Prescribing Opioids.

Roy Fleischmann, MD, discusses the usage of biosimilars in the United States and hypothesizes about what is in store for the future.

In the most recent episode of Don't Miss a Beat, co-hosts Drs. Vaduganathan and Greene are joined by Dr. Eugene Braunwald for a conversation that touches on the founding of the TIMI Study Group, the evolution of clinical trials, and advice he would give to early career professionals with an interest in becoming trialists.

Investigators study the overall clinical, humanistic, and economic burden of conversion therapy - a dangerous and discredited practice - to inform legal and health care policy makers.

A look into the uptake of semaglutide, what the agent represents, and what is coming further in obesity management.